Similar articles

• [Isolation and use of thrombocyte and leukocyte concentrates].

  Kalinin NN. Kalinin NN. Probl Gematol Pereliv Krovi. 1980 Oct;25(10):50. Probl Gematol Pereliv Krovi. 1980. PMID: 6999495 Review. Russian. No abstract available.
• Which are the parameters to be controlled in platelet concentrates in order that they may be offered to the medical profession as a standardized product with specific properties?

  [No authors listed] [No authors listed] Vox Sang. 1981 Feb;40(2):115-26. Vox Sang. 1981. PMID: 7233883 No abstract available.
• The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.

  Levy L, Woodfield DG. Levy L, et al. N Z Med J. 1984 Oct 24;97(766):719-21. N Z Med J. 1984. PMID: 6595558
• [Thrombopheresis with the CS-3000 cell separator. Changes in primary hemostasis in the donor and in concentrates in 8-day storage].

  Budde U. Budde U. Beitr Infusionther Klin Ernahr. 1986;15:75-81. Beitr Infusionther Klin Ernahr. 1986. PMID: 3092802 German. No abstract available.
• Identification & management of defects in platelet hemostasis in massively transfused patients.

  Slichter SJ. Slichter SJ. Prog Clin Biol Res. 1982;108:225-58. Prog Clin Biol Res. 1982. PMID: 6757960 Review. No abstract available.